Alerus Financial NA Acquires 6,186 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Alerus Financial NA boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 177.1% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 9,678 shares of the medical equipment provider’s stock after buying an additional 6,186 shares during the quarter. Alerus Financial NA’s holdings in Intuitive Surgical were worth $5,052,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently made changes to their positions in the company. Norges Bank bought a new stake in Intuitive Surgical during the 4th quarter valued at $2,401,493,000. Proficio Capital Partners LLC lifted its stake in Intuitive Surgical by 89,098.8% in the fourth quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock worth $495,845,000 after acquiring an additional 948,902 shares during the period. Raymond James Financial Inc. purchased a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $313,769,000. Wilmington Savings Fund Society FSB lifted its holdings in Intuitive Surgical by 15,322.2% during the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after buying an additional 552,058 shares during the period. Finally, Vanguard Group Inc. increased its holdings in shares of Intuitive Surgical by 1.1% in the 4th quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider’s stock valued at $16,813,478,000 after acquiring an additional 360,591 shares during the period. Institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In related news, VP Fredrik Widman sold 810 shares of the firm’s stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $573.78, for a total transaction of $464,761.80. Following the completion of the sale, the vice president now directly owns 473 shares in the company, valued at approximately $271,397.94. This trade represents a 63.13 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Mark Brosius sold 492 shares of the business’s stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $573.78, for a total transaction of $282,299.76. Following the completion of the transaction, the senior vice president now owns 4,056 shares in the company, valued at $2,327,251.68. The trade was a 10.82 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 33,754 shares of company stock valued at $17,691,621. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Price Performance

ISRG opened at $507.90 on Friday. The firm has a market capitalization of $180.90 billion, a price-to-earnings ratio of 79.24, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. The company’s 50 day simple moving average is $558.29 and its two-hundred day simple moving average is $532.25. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on ISRG shares. Stifel Nicolaus lifted their target price on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, December 5th. Truist Financial reduced their price objective on shares of Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating for the company in a research note on Monday, March 17th. Barclays raised their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. UBS Group increased their price objective on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a report on Monday, January 27th. Finally, Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $611.86.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.